Welcome to Intercytex Ltd. We are a UK Regenerative Medicine Company product and services company launced in Nov 2010. We are focussed on developing our lead product ICX-RHY (VAVELTA) to treat a variety of skin related problems including Epidermolysis Bullosa and scar contractures as well as providing our Cell2Therapy Translation service to other Regenerative Medicine based companies and Research Groups in order to enable them to take their cell therapy rapidly into the clinic.